A report from the Innovation Economy Council, an industry coalition, argues that Canada’s biomanufacturing strategy must look beyond vaccines and move into the even more important field cell and gene therapies. Federal support will be crucial to ensuring that these facilities are located in innovation centres across the country where they can thrive.
Organization: Centre for Commercialization of Regenerative Medicine
The Short Report – August 4, 2021: Ottawa’s new biomanufacturing and life sciences strategy, a national startup job board, rural transit solutions, and more
Ottawa prepares for future pandemics with launch of life science strategy, CellCAN and CCRM launch a new cell and gene therapy institute to tackle gaps in training, a new fund dedicated to developing transit solutions for rural and remote communities, and more.
The Short Report – May 5, 2021: Federal government invests in vaccine uptake, Carleton U embarks on aging project, $5 million for new ocean supercluster projects, and more
This week in The Short Report, the Canadian Association of Science Centres receives funding to address vaccine misinformation while U of T targets strategies to reduce fear of needles; the University of Alberta receives industry funding to bolster wheat-breeding capacity, the Rideau Hall Foundation recognizes excellence in innovation, and more.
The Short Report – Nov. 18th, 2020: New stem cell bioproduction facility; new fund for female businesses, and more…
Vivek Goel will be UWaterloo’s seventh president and vice-chancellor; aerial drone technology gets a major boost in funding.
The Short Report – May 20, 2020: Last network renewals for sunsetting NCE program; New accelerator targets healthy living; Canadian health research at “elevated risk” for hacking; and more
The Networks of Centres of Excellence has awarded $80.7 million in funding to five networks – the last cohorts to be renewed as the NCE program begins winding down over the next few years. Three-year renewals were granted to: Aging Gracefully across Environments using Technology to support Wellness, Engagement and Long Life (AGE-WELL) ($22 million);…
The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more
Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…
Five CECRs receive $78.9 million in new funding in competition geared towards existing centres
The federal government has finally announced the results of last year’s competition for existing Centres of Excellence for Commercialization and Research (CECR), with five returning centres sharing $78.9 million over five years. The successful CECRs were chosen from a field of 25 letters of intent and 10 full applications, all of which were previously or are currently receiving funding through the program.
Canada’s regenerative medicine sector poised to soar with better funding and collaboration: report
Canadian expertise and achievements in regenerative medicine (RM) could be at a turning point if strategic steps are taken to increase stable funding and achieve greater coordination among the many federal and provincial players. Those are the key observations of a report issued by the Council of Canadian Academies (CCA), which was based on a two-day workshop held last October to provide policy makers with pointers for growing the sector and realizing greater economic and health benefits.
CCRM announces 13 new industry members
The Centre for Commercialization of Regenerative Medicine (CCRM) has added 13 new companies to its industry consortium as associate members, bringing the company total to nearly 40. The consortium is a key element of CCRM — a Quebec-based network funded by the Centres of Excellence for Commercialization and Research — and its objective of building…
CCRM adds Sernova to industry-based consortium
The Centre for Commercialization of Regenerative Medicine (CCRM) — a Network of Centres of Excellence — has added a new member to its industry consortium, bringing the number of member companies to more than 20. Sernova Corp, London ON, will bring its expertise in cell therapy for the treatment of chronic diseases to CCRM. The…
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...